Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-093308
Filing Date
2024-08-08
Accepted
2024-08-08 07:10:26
Documents
72
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q aura-20240630.htm   iXBRL 10-Q 2140429
2 EX-3.1 aura-ex3_1.htm EX-3.1 65697
3 EX-10.1 aura-ex10_1.htm EX-10.1 21044
4 EX-31.1 aura-ex31_1.htm EX-31.1 17194
5 EX-31.2 aura-ex31_2.htm EX-31.2 17044
6 EX-32.1 aura-ex32_1.htm EX-32.1 15443
  Complete submission text file 0000950170-24-093308.txt   8383691

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT aura-20240630.xsd EX-101.SCH 1222271
74 EXTRACTED XBRL INSTANCE DOCUMENT aura-20240630_htm.xml XML 1311223
Mailing Address 80 GUEST STREET BOSTON MA 01235
Business Address 80 GUEST STREET BOSTON MA 01235 (617)500-8864
Aura Biosciences, Inc. (Filer) CIK: 0001501796 (see all company filings)

EIN.: 320271970 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40971 | Film No.: 241186010
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)